References
Original article
Marin, D. et al. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial. Nat. Med. https://doi.org/10.1038/s41591-023-02785-8 (2024)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Romero, D. Promising early results with CAR NK cells. Nat Rev Clin Oncol 21, 168 (2024). https://doi.org/10.1038/s41571-024-00866-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-024-00866-2
- Springer Nature Limited